Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Human dental pulp mesenchymal stem cells (hDP-MSCs), also known as human dental pulp stem cells (DPSCs), are a population of multipotent mesenchymal stromal/stem cells isolated from the dental pulp tissue of adult or deciduous teeth. These cells exhibit high proliferative capacity, clonogenicity, and self-renewal. They can differentiate into multiple cell types including osteoblasts (bone), chondrocytes (cartilage), adipocytes (fat), neural-like cells, odontoblasts (dentin-forming), and others. hDP-MSCs possess immunomodulatory properties and secrete various growth factors such as BDNF, GDNF, NGF, NT-3, angiopoietin 1 (ANGPT1), and VEGF that contribute to tissue repair via paracrine effects[1][2]. Their primary mechanisms include promoting regeneration in bone defects[5], neural tissues[1], dentin-pulp complex[2], periodontal tissues[6], and other organs. They are being investigated for use in regenerative medicine for conditions such as chronic periodontitis[6], spinal cord injury, neurodegenerative diseases like Parkinson’s disease and Alzheimer’s disease[2], myocardial infarction, muscular dystrophy, diabetes mellitus, liver diseases,[2] eye diseases,[7] immune disorders,[2] oral/maxillofacial defects,[3][5] among others.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on human dental pulp mesenchymal stem cells.